Real-World Survey Outcomes For Chronic Spontaneous Urticaria For Patients On Omalizumab Versus Patients Eligible For Omalizumab

被引：0
|
作者：
Holden, Michael [1 ]
Bernstein, Jonathan [2 ]
Seetasith, Arpamas [1 ]
Garmo, Vincent [1 ]
Hetherington, James [3 ]
Hoskin, Ben [3 ]
Wrest, Eleanor [3 ]
Casale, Thomas [4 ]
机构：
[1] Genentech Inc, San Francisco, CA USA
[2] Univ Cincinnati, Cincinnati, OH USA
[3] Adelphi Real World, Adelphi, MD USA
[4] Univ S Florida, Tampa, FL USA
来源：
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2023年 / 151卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
577
引用
收藏
页码：AB187 / AB187
页数：1
相关论文
共 50 条
  • [1] OMALIZUMAB USE IN PATIENTS WITH CHRONIC SPONTANEOUS URTICARIA: A REAL-WORLD SURVEY IN THE UNITED STATES
    Holden, M.
    Seetasith, A.
    Hetherington, J.
    Wrest, E.
    Keal, A.
    Salmon, P.
    Mosnaim, G.
    [J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2023, 131 (05) : S41 - S41
  • [2] REAL-WORLD EFFECTIVENESS OF OMALIZUMAB IN PATIENTS TREATED FOR CHRONIC SPONTANEOUS URTICARIA
    Garmo, V.
    Seetasith, A.
    Holden, M.
    Broder, M.
    Chang, E.
    Tarbox, M.
    Mosnaim, G.
    [J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2023, 131 (05) : S33 - S33
  • [3] Real-world outcomes in patients with chronic spontaneous urticaria receiving omalizumab: insights from a clinical practice survey
    Seetasith, Arpamas
    Holden, Michael
    Hetherington, James
    Keal, Aaron
    Salmon, Phoebe
    Bernstein, Jonathan A.
    Casale, Thomas B.
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2024, 40 (06) : 1059 - 1066
  • [4] Real-world dosing of omalizumab for chronic spontaneous urticaria
    McIntyre, Amanda P.
    Viswanathan, Ravi K.
    Moss, Mark H.
    Mathur, Sameer K.
    [J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2020, 124 (02) : 211 - 212
  • [5] Real-world use of omalizumab in patients with chronic idiopathic/spontaneous urticaria in the United States
    Eghrari-Sabet, Jacqueline
    Sher, Ellen
    Kavati, Abhishek
    Pilon, Dominic
    Zhdanava, Maryia
    Balp, Maria-Magdalena
    Lefebvre, Patrick
    Ortiz, Benjamin
    Bernstein, Jonathan A.
    [J]. ALLERGY AND ASTHMA PROCEEDINGS, 2018, 39 (03) : 191 - 200
  • [6] Real-world treatment patterns and outcomes of omalizumab use in patients with chronic idiopathic urticaria
    Wang, Liya
    Ke, Xuehua
    Kavati, Abhishek
    Wertz, Debra
    Huang, Qing
    Willey, Vincent J.
    Stephenson, Judith J.
    Ortiz, Benjamin
    Paknis, Brandee
    Bernstein, Jonathan A.
    Beck, Lisa A.
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2018, 34 (01) : 35 - 39
  • [7] OMALIZUMAB TREATMENT OF CHRONIC SPONTANEOUS URTICARIA: EFFECTIVENESS AND SATISFACTION ASSESSED BY A REAL-WORLD SURVEY
    Casale, T.
    Seetasith, A.
    Hetherington, J.
    Hoskin, B.
    Wrest, E.
    Garmo, V.
    Holden, M.
    Bernstein, J.
    [J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2022, 129 : S27 - S27
  • [8] Strategies for Discontinuing Omalizumab in Patients with Chronic Urticaria: Real-World Findings
    Seghezzo, Sara
    Tsao, Lulu
    Otani, Iris M.
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2019, 143 (02) : AB302 - AB302
  • [9] Omalizumab Updosing in Chronic Spontaneous Urticaria: an Overview of Real-World Evidence
    Martin Metz
    Zahava Vadasz
    Emek Kocatürk
    Ana M. Giménez-Arnau
    [J]. Clinical Reviews in Allergy & Immunology, 2020, 59 : 38 - 45
  • [10] Effectiveness of Hydroxychloroquine and Omalizumab in Chronic Spontaneous Urticaria: A Real-World Study
    Khan, Najeeb
    Epstein, Tolly G.
    DuBuske, Ilona
    Strobel, Maria
    Bernstein, David I.
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2022, 10 (12): : 3300 - 3305
12345